EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

IgG4-Related Cholangitis

Ulrich Beuers, David C Trampert

Seminars in Liver Disease · 01.09.2025 · 45 (03) · 381-396

DOI: 10.1055/a-2588-3875 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Liver Disease, erschienen am 01.09.2025. Verfasst von Ulrich Beuers und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Tytgat Institute for Liver and Intestinal Research, AGEM, Amsterdam University Medical Center, Amsterd…. Hauptthemen laut MEDLINE: Immunoglobulin G4-Related Disease, Cholangitis, Immunoglobulin G. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ZonMw Open Competition grant of the Netherlands Organization for Scientific Research, South African PSC patient foundation (Stichting AMC Foundation).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

IgG4-related cholangitis (IRC) is a rare fibroinflammatory disease of the biliary tree and liver and presents the major hepatobiliary manifestation of IgG4-related systemic disease (IgG4-RD). IRC also includes the IgG4-related inflammatory pseudotumor of the liver and IgG4-related cholecystitis. IRC mimics other cholangiopathies such as primary sclerosing cholangitis or cholangiocarcinoma. IRC may be found in 30 to 60% of cases with type 1 autoimmune pancreatitis, the most frequent manifestation of IgG4-RD. The pathogenesis of IRC (and IgG4-RD) is incompletely understood. Genetic predisposition, environmental factors, oligoclonal glucocorticosteroid-sensitive expansion of IgG4+ B cells/plasmablasts in blood and affected tissue and blocking autoantibody formation against protective IgG4-specific autoantigens such as annexin A11 and laminin 511-E8 with impaired protection of biliary epithelia against toxic bile acids have been described in IRC. Specific T cell subtypes are involved in the inflammatory process. The diagnosis of IRC is made according to HISORt criteria comprising histopathology, imaging, serology, other organ manifestations, and response to therapy. Treatment of IRC aiming to prevent organ failure and improve symptoms includes remission induction with highly effective glucocorticosteroids and long-term maintenance of remission with immunomodulators such as glucocorticosteroid sparing additives or B cell depleting approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunoglobulin G4-Related DiseaseCholangitisImmunoglobulin GHumansGlucocorticoidsTreatment OutcomeDiagnosis, Differential

Substanzen

Immunoglobulin GGlucocorticoids

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Tytgat Institute for Liver and Intestinal Research, AGEM, Amsterdam University Medical Center, Amsterdam, The Netherlands.

Förderung

  • ZonMw Open Competition grant of the Netherlands Organization for Scientific Research
  • South African PSC patient foundation (Stichting AMC Foundation)

Zitieren

APA

Beuers, U., & Trampert, D. C. (2025). IgG4-Related Cholangitis. Seminars in Liver Disease, 45(03), 381-396. https://doi.org/10.1055/a-2588-3875

Vancouver

Beuers U, Trampert DC. IgG4-Related Cholangitis. Seminars in Liver Disease. 2025;45(03):381-396. doi:10.1055/a-2588-3875

BibTeX
@article{Beuers2025,
  author = {Beuers, Ulrich and Trampert, David C},
  title = {IgG4-Related Cholangitis},
  journal = {Seminars in Liver Disease},
  year = {2025},
  volume = {45},
  number = {03},
  pages = {381--396},
  doi = {10.1055/a-2588-3875}
}
Kostenlos starten →